openPR Logo
Press release

Bronchodilators Market Competitive Landscape by 2024

01-11-2018 11:24 AM CET | Health & Medicine

Press release from: Persistence Market Research

Bronchodilators is the medication that is taken to improve breathing and are used for treating breathing related symptoms that are associated with allergic reaction. It is also used for expanding the airways and improving the breathing capacity function of patients with chronic obstructive pulmonary disease (COPD), bronchial asthma, emphysema, and other lung diseases. Bronchodilators function by relaxing the muscle surrounding the airways. These products are available over the counter or requires prescription.

Basically there are available in three forms injectable, oral and inhaled. In oral forms they come in variety such as liquids, tablets and capsules, these oral forms are delivered in higher doses which is directly absorbed into the bloodstream and so they have relatively more side effects. Whereas inhaled once are directly deposited in the lungs causing less side effects. Bronchodilators are of basically-acting or long-acting beta2-agonists and anticholinergic agents or theophylline. They function so as to control asthma and COPD. Short acting bronchodilators function for fast relief of asthma symptoms and long acting bronchodilators function for control symptoms of asthma. The Bronchodilators market is driven by increasing prevalence of chronic conditions and advancement in technology.

According to the Centers for Disease and Control of Infection, in 2014 number of adults who had asthma was 17.7 million. It seen more in female over male, and caused 3,651 number of deaths. According World Health Organization, in 2012 over 3 million people died due to COPD, which is equal to 6% of all deaths globally that year. These death mostly occurred in low- and middle-income countries, and the risk factors included air pollution caused by cooking and heating, outdoor air pollution, pollution due to dust and chemicals (vapor’s, irritants and fumes), and lower respiratory infections during childhood. Above mentioned are some of the leading causes of preventable death.

Request Report For TOC @ https://www.persistencemarketresearch.com/toc/12241

Moreover due to government initiatives and rising healthcare expenditure it is expected to fuel the bronchodilators market over the forecast period. Also factors such as rising adoption of these products, and patient education program that are conducted by government and companies for creating the awareness among the general population is likely to drive the growth of bronchodilators market over forecast period. However Bronchodilators market has some restraints such as low awareness for these products and cost of treatment is expected to hinder the growth of the bronchodilators market.

Rise in the incidence of COPD, asthma is expected to boost the bronchodilators market over the forecast period. In addition rising awareness among general population and physician adopting these products and prescribing these drugs is expected to drive the bronchodilators market during the forecast period.

Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/12241

Geographically the bronchodilators market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific and MEA region.

North America followed by Europe is dominating the bronchodilators market as high incidence of COPD and asthma cases. Apart from these combination therapies are becoming more popular and preferred choice of treatment in the U.S. as they have better efficacy. In Asia Pacific region the bronchodilators market is expected to deliver significant growth as China is the world’s largest tobacco producer and accounts for 42% globally for cigarette production. According to WHO, majority of the world’s smoking population is present in China, this is expected to boost the demand for bronchodilators products over the forecast period.

Some of the major companies in the bronchodilators market are Ache Laboratorios Farmaceuticos, Aquinox Pharmaceuticals, BioMarck Pharmaceuticals, F. Hoffmann-La Roche, Gilead Sciences, Innoviva, MediciNova, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline plc, Merck & Co., Inc., Novartis Ag, and others

Pre Book Full Report @ https://www.persistencemarketresearch.com/checkout/12241

About Us

Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact

Persistence Market Research Pvt. Ltd

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

media@persistencemarketresearch.com

Web:www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bronchodilators Market Competitive Landscape by 2024 here

News-ID: 895781 • Views:

More Releases from Persistence Market Research

Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview: The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period. Market Size and Growth: The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and
The Global Graphene Market's Striking Growth and Innovative Applications
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities. Get Access To
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analysis, Emerging Trends with Upcoming Developments
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview: The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033. The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation and Industry Size
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products. To obtain the latest market

All 5 Releases


More Releases for Bronchodilators

Bronchodilators Market : Industry Size, Share, Growth, Forecasts 2017 - 2025
MarketResearchReports.Biz announces addition of new report "Bronchodilators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its database. The objectives of this study are as follows: To define, describe, and forecast the "Bronchodilators" market by type, application, component, delivery model, end user, and region To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges) To analyze micromarkets with respect to individual growth
Bronchodilators Market to Observe Strong Development by 2025
According to the report, the global Bronchodilators Market is majorly driven by an increasing focus on the development of monoclonal antibody therapy. Monoclonal antibody therapy is increasingly being used for the treatment of diseases such as tumour, which in turn has inspired market players to double their efforts and focus on the development of monoclonal antibody therapy. The positive results shown by monoclonal antibody therapy is expected to increase its
Bronchodilators Market Size, Status and Forecast to 2025
According to the report, the global bronchodilators market is majorly driven by an increasing focus on the development of monoclonal antibody therapy. Monoclonal antibody therapy is increasingly being used for the treatment of diseases such as tumour, which in turn has inspired market players to double their efforts and focus on the development of monoclonal antibody therapy. The positive results shown by monoclonal antibody therapy is expected to increase its
Discover the Growth of the Bronchodilators Market
Bronchodilators is the medication that is taken to improve breathing and are used for treating breathing related symptoms that are associated with allergic reaction. It is also used for expanding the airways and improving the breathing capacity function of patients with chronic obstructive pulmonary disease (COPD), bronchial asthma, emphysema, and other lung diseases. Bronchodilators function by relaxing the muscle surrounding the airways. These products are available over the counter or
Bronchodilators Market Plying for Significant Growth During 2016 - 2024
Bronchodilators is the medication that is taken to improve breathing and are used for treating breathing related symptoms that are associated with allergic reaction. It is also used for expanding the airways and improving the breathing capacity function of patients with chronic obstructive pulmonary disease (COPD), bronchial asthma, emphysema, and other lung diseases. Bronchodilators function by relaxing the muscle surrounding the airways. These products are available over the counter or
2017 United States Bronchodilators Market Embraces Advancements
In this report, the United States Bronchodilators market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Bronchodilators in these regions, from